Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by wagyusteakon Jul 21, 2020 8:20pm
35 Views
Post# 31299304

RE:RE:RE:RE:RE:Share price at $6.77 ...

RE:RE:RE:RE:RE:Share price at $6.77 ...
Benedict16th wrote: So when GUD bought GBT and paid FOR the 51% in November the Brazilian Real WAS  .35 to the canadian dollar, now the Real is .26. That is over 30% depretiation and hair cut that GUD took. We still do not know and it is a secret "in GUD MNGT mind"  how are they paying for the .49%. Did they edge the .49% and taking another haircut or are they paying the rest with a 30% with discount due to the depratiation of the Real? Should they not tell shareholders what the facts are? Remember the earning in Canadian dollars should also be 30% less. ARE this MNGT jenius?  I do not know as the facts and foggy so far.  But the market knws. 



Btw, the market is just like you. lazy and don't want to do their own homework.
Bullboard Posts